LD-2 disclosure · 3rd Quarter - Report
EMERGENT BIOSOLUTIONS INC.
Income$50Kfee reported
Client
- Name
- EMERGENT BIOSOLUTIONS INC.
- Description
- chemical and vaccine manufacturing
- Location
- Maryland · United States of America
Registrant
- Description
- Government Affairs Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueDisaster Planning/Emergencies
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; NDAA for Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone.
LobbyistsJAMES L ERVIN · DANIEL SAUERS · MATTHEW MARSH
TargetedSENATE · HOUSE OF REPRESENTATIVES